
By Benjamin Cuaresma
Ilocos Norte has emerged as a national model for cervical cancer prevention after achieving 95.7% human papillomavirus (HPV) vaccination coverage among girls aged 9 to 14, surpassing the government’s 90% target.
Of the 23,031 girls targeted for vaccination, 22,039 have received the HPV vaccine, which protects against the virus responsible for most cases of cervical cancer.
The achievement was highlighted during a gathering in Laoag City organized by the Department of Health (DOH)–Ilocos Region in partnership with the provincial government, Provincial Health Office, Mariano Marcos Memorial Hospital and Medical Center, and the FPOGS–Ilocos Norte Chapter.
Carrying the theme “From Milestone to Movement: Ilocos Norte Sets National Model for a Cervical Cancer-Free Philippines,” the event recognized the province’s vaccination campaign and outlined measures to sustain its gains.
The HPV vaccine provides the strongest protection when administered before exposure to the virus, making early vaccination a critical component of cervical cancer prevention.
Health authorities and provincial partners are now focusing on three priorities: ensuring that eligible girls who missed vaccination and newly eligible nine-year-olds are covered through routine immunization; countering misinformation through community education and media partnerships; and strengthening cervical cancer screening and timely treatment for women.
The integrated approach aims to maintain vaccination coverage above 90% while ensuring that prevention extends beyond immunization to include screening and appropriate medical care.
Ilocos Norte’s experience is being considered a model for other provinces seeking to expand HPV vaccination, strengthen public confidence in immunization and establish sustainable programs against cervical cancer.
The initiative underscores the importance of coordinated action among government agencies, health professionals, schools, communities and families in preventing a disease that can be substantially reduced through vaccination, screening and early treatment.
ia/xf
